GSTM1 and anemia (phenotype): This increased the total number of patients with anemia (Hb ≤ 7 g/dl) a week or more after the start of therapy to 192, although most were detected on day 7 due to sampling bias, as the last scheduled blood sampling per protocol in our study was day 7.